Viridian Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

Go back to Viridian Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
(NASDAQ: VRDN) Delayed: 17.32 +0.04 (0.23%)
Previous Close $17.28    52 Week High
Open $17.50    52 Week Low
Day High $17.78    P/E N/A 
Day Low $17.16    EPS
Volume 1,269,031